These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7521441

  • 1. [Anti-interferon antibody in chronic hepatitis C].
    Arai K, Shindo M, Okuno T.
    Nihon Rinsho; 1994 Jul; 52(7):1929-34. PubMed ID: 7521441
    [Abstract] [Full Text] [Related]

  • 2. The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
    Hosoi H, Imai M, Yamanaka M.
    J Gastroenterol Hepatol; 1992 Jul; 7(4):411-6. PubMed ID: 1515568
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G, Currenti M, Turriziani O, Dianzani F.
    J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
    [Abstract] [Full Text] [Related]

  • 6. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
    Spiegel RJ, Jacobs SL, Treuhaft MW.
    J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
    [Abstract] [Full Text] [Related]

  • 7. [The influence of anti-interferon-alpha 2a antibodies in initial daily four-week interferon-alpha 2a therapy for chronic hepatitis C].
    Habu D, Mizuno M, Ohnishi K, Watanabe A, Son J, Iwano M, Murakoshi R, Takino T, Mizuma Y, Kobayashi M.
    Nihon Shokakibyo Gakkai Zasshi; 1997 May; 94(5):319-27. PubMed ID: 9170879
    [Abstract] [Full Text] [Related]

  • 8. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX, Hua J, Smith T, Ferencz-Biro K, Liao MJ, Rashidbaigi A.
    Hum Antibodies; 1997 May; 8(3):129-36. PubMed ID: 9322083
    [Abstract] [Full Text] [Related]

  • 9. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M, Antonelli G, Santantonio T, Giannelli G, Currenti M, Monno L, Turriziani O, Pastore G, Dianzani F.
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection.
    Milella M, Antonelli G, Santantonio T, Currenti M, Monno L, Mariano N, Angarano G, Dianzani F, Pastore G.
    Liver; 1993 Jun; 13(3):146-50. PubMed ID: 8336526
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.
    von Wussow P, Jakschies D, Freund M, Deicher H.
    J Interferon Res; 1989 Sep; 9 Suppl 1():S25-31. PubMed ID: 2809276
    [Abstract] [Full Text] [Related]

  • 14. Does the presence of serum autoantibodies influence the responsiveness to interferon-alpha 2a treatment in chronic hepatitis C?
    Wada M, Kang KB, Kinugasa A, Shintani S, Sawada K, Nishigami T, Shimoyama T.
    Intern Med; 1997 Apr; 36(4):248-54. PubMed ID: 9187562
    [Abstract] [Full Text] [Related]

  • 15. Detection of anti-interferon-alpha 2a antibodies in chronic liver disease.
    Ikeda Y, Miyake K, Toda G, Yamada H, Yamanaka M, Oka H.
    J Gastroenterol Hepatol; 1989 Apr; 4(5):411-8. PubMed ID: 2491207
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia.
    Bekisz JB, zur Nedden DL, Enterline JC, Zoon KC.
    J Interferon Res; 1989 Sep; 9 Suppl 1():S1-7. PubMed ID: 2809275
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
    Russo D, Candoni A, Zuffa E, Minisini R, Silvestri F, Fanin R, Zaja F, Martinelli G, Tura S, Botta G, Baccarani M.
    Br J Haematol; 1996 Aug; 94(2):300-5. PubMed ID: 8759890
    [Abstract] [Full Text] [Related]

  • 18. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.
    Brand CM, Leadbeater L, Bellati G, Marotta F, Ideo G.
    J Interferon Res; 1993 Apr; 13(2):121-5. PubMed ID: 7685368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG, Smith JW, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH.
    Blood; 1991 Feb 15; 77(4):792-8. PubMed ID: 1704264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.